Baylor Genetics’s Dr. Christine Eng and Chris Sands explore the power of whole genome sequencing when paired with multi-omic technology, like long-read sequencing, optical genome mapping, and RNA sequencing.
All tagged exome
#303 RNA Analysis with Ambry Genetics
Dr. Rachid Karam explains how RNA testing increases diagnostic yield and reduces variants of uncertain significance in cancer and exomes.
#297 Exome Reanalysis with Ambry Genetics
The “Patient For Life” exome reanalysis program is explored with Ambry Genetics’ Chief Medical Officer, Dr. Elizabeth Chao, and the VP of Medical Affairs and a seasoned Genetic Counselor, Kelly Hagman.
#268 Optical Genome Mapping and Transcriptome Analysis with Peter Nagy
Praxis Genomics’ Chief Medical Officer explains how these genetic technologies can provide advantages over traditional testing methods.
#215 Preventative Health via Whole Exome Sequencing
The Founder and CEO of Panacea discusses utilizing whole exome sequencing for preventive health.
#206 Phenotypically-Driven Clinical Results with Dr. Lora Bean
Dr. Lora Bean, Senior Director of Quality Assurance at PerkinElmer Genomics, discusses the role that phenotypic data plays in analyzing genetic data.
#82 Smith Family Clinic on Whole Genome Sequencing
The power of whole genome sequencing for patients with undiagnosed diseases.